Mergers & Acquisitions - Bayer


Current filters:


Popular Filters

Bayer to buy Chinese OTC/TCM drugmaker Dihon Pharma


Germany’s leading pharma firm Bayer says it plans to acquire 100% of Dihon Pharmaceutical, a privately…

BayerDihon PharmaceuticalMergers & AcquisitionsPharmaceutical

Way clear for Bayer to complete Algeta acquisition


The way is now clear for Germany’s Bayer to acquire Norwegian pharmaceutical company Algeta, under…

AlgetaBayerMergers & AcquisitionsOncologyPharmaceuticalXofigo

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds


German pharma and life sciences group Bayer says it is taking advantage of currently low interest rates…

AlgetaBayerFinancialMergers & AcquisitionsPharmaceutical

Bayer confirms plans to acquire Norway’s Algeta

Bayer confirms plans to acquire Norway’s Algeta


German drugs and chemicals major Bayer has officially announced its intention to acquire Norwegian pharmaceutical…

AlgetaBayerGermanyMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

Norway’s Algeta confirms takeover bid approach from Bayer

Norway’s Algeta confirms takeover bid approach from Bayer


In response to recent media commentary, the board of directors of Norway’s Algeta this morning confirmed…

AlgetaBayerMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

Onyx Pharma accepts increased bid from Amgen


Amgen (Nasdaq: AMGN), the world largest independent biotech group, said on Sunday (August 25) that the…

AmgenBayerBiotechnologyKyprolisMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizer

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer


Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

Bayer to strengthen consumer business with Steigerwald acquisition


Germany's Bayer (BAYN: DE) has signed an agreement to acquire 100% of the shares of Steigerwald Arzneimittelwerk…

BayerMergers & AcquisitionsPharmaceuticalSteigerwald

Bayer to acquire Conceptus for about $1.1 billion


German drugs and chemical major Bayer (BAYN: DE) has signed an agreement to acquire Conceptus (Nasdaq:…

BayerConceptusEssureMergers & AcquisitionsPharmaceuticalReproductiveWomen's Health

Reckitt Benckiser trumps Bayer's bid for control of Schiff Nutritional


In a move that looks set to thwart Germany-based Bayer's (BAYN: DE) plans to acquire the US nutritional…

BayerMergers & AcquisitionsPharmaceuticalReckitt BenckiserSchiff Nutrition International

News briefs: GlaxoSmithKline and Bayer


UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Piramal buys molecular imaging portfolio from Bayer


Indian drugmaker Piramal Healthcare (BSE: 500302) says it has signed an agreement to acquire worldwide…

BayerflorbetabenMergers & AcquisitionsPharmaceuticalPiramal Healthcare

Spectrum Pharma to acquire non-US rights to market Zevalin


USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Back to top